Janus Henderson Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,099,328
Closed -$166M 2664
2022
Q3
$166M Buy
1,099,328
+23,862
+2% +$3.54M 0.06% 262
2022
Q2
$157M Sell
1,075,466
-1,630,686
-60% -$208M 0.11% 193
2022
Q1
$321M Buy
2,706,152
+1,299,597
+92% +$162M 0.15% 155
2021
Q4
$194M Buy
1,406,555
+641,180
+84% +$81.5M 0.08% 237
2021
Q3
$106M Buy
765,375
+27,480
+4% +$3.43M 0.05% 349
2021
Q2
$71.6M Buy
737,895
+19,855
+3% +$1.61M 0.03% 464
2021
Q1
$49.1M Buy
+718,040
New +$58.1M 0.02% 555
2019
Q2
Sell
-1,251,607
Closed -$64.4M 1442
2019
Q1
$64.4M Sell
1,251,607
-1,892,151
-60% -$81.7M 0.04% 514
2018
Q4
$116M Sell
3,143,758
-193,158
-6% -$6.96M 0.07% 308
2018
Q3
$125M Buy
3,336,916
+37,616
+1% +$1.38M 0.07% 335
2018
Q2
$130M Sell
3,299,300
-96,830
-3% -$3.07M 0.07% 318
2018
Q1
$87.5M Buy
3,396,130
+2,416,021
+247% +$72.2M 0.05% 403
2017
Q4
$26.4M Buy
980,109
+291,200
+42% +$8.02M 0.02% 686
2017
Q3
$25.8M Buy
688,909
+43,166
+7% +$1.31M 0.02% 680
2017
Q2
$16.1M Buy
+645,743
New +$14.9M 0.01% 785

Other funds holding BHVN